In our study, treatment with ER1626, ERβ protein was raised in MCF-7 and Ishikawa cells, which suggested the mechanism of anti breast cancer and endometrial cancer of ER1626 was associated with the increment of ERβ protein. The gene discussed is ESR2; the disease is breast carcinoma.